4.5 Article

Cross-priming of CD8(+) T cells by viral and tumor antigens is a robust phenomenon

Journal

EUROPEAN JOURNAL OF IMMUNOLOGY
Volume 34, Issue 1, Pages 194-199

Publisher

WILEY
DOI: 10.1002/eji.200324257

Keywords

CTL; cross-priming; MHC; virus; tumor

Categories

Funding

  1. NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000814, Z01AI000814] Funding Source: NIH RePORTER

Ask authors/readers for more resources

Cross-priming refers to the activation of naive CD8(+) T cells by antigen-presenting cells that have acquired nominal antigens from another cell. The biological relevance of cross-priming of CD8(+)T cells has recently been challenged (Zinkernagel, R. M., Eur J. Immunol. 2002. 32: 2385-2392), on the basis that responses are weak or poorly quantitated, and the determinants recognized are undefined. Here we show that cross-priming is a robust process that elicits vigorous primary responses to multiple pepticles in two well-defined systems. Our findings support the relevance of cross-priming in CD8(+) T cell responses to viruses and tumor cells, and demonstrate that cross-priming elicits CD8(+) T cells to determinants generated by the endogenous processing pathway.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available